Article Versions Notes

Han B, Liu W, Du J, Liu H, Zhao T, Yang S, Wang S, Zhang S, Liu B, Liu Y, et al. 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. Vaccines. 2021; 9(12):1407. https://doi.org/10.3390/vaccines9121407

Han, Bingfeng, Wu Liu, Juan Du, Hanyu Liu, Tianshuo Zhao, Shubo Yang, Shuai Wang, Sihui Zhang, Bei Liu, Yaqiong Liu, and et al. 2021. "12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial" Vaccines 9, no. 12: 1407. https://doi.org/10.3390/vaccines9121407

Han, B., Liu, W., Du, J., Liu, H., Zhao, T., Yang, S., Wang, S., Zhang, S., Liu, B., Liu, Y., & Cui, F. (2021). 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. Vaccines, 9(12), 1407. https://doi.org/10.3390/vaccines9121407